Encinitas, CA, US • 50 - 99 Employees
BioTech/Drugs
Viracta is focused on advancing a proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr Virus, and will pursue opportunities to address other serious virus-associated disease.
CancerLymphoproliferative DisordersNasopharyngeal CarcinomaEBV LymphomaImmuno-OncologyOncologyClinicalGastric CancerBreast Cancer